About
Drug Development
Areas of Focus
Categories
Contract ManufacturingContract ResearchSan Diego & Southern California
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
1,449
By Phase
PHASE3: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT02633813Lead Sponsor
BE Study of Naftifine HCL
PHASE3Completed
693 participants
Started: Mar 31, 2015 · Completed: Dec 31, 2015
NCT02734459Collaborator
A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery
PHASE3Completed
756 participants
Started: Nov 30, 2013 · Completed: Mar 31, 2016
Locations (1)
Headquarters
Los Angeles, CA, United States
Map
Loading map...